Stage IV Colorectal Cancer Completed Phase 2 Trials for Clobetasol propionate (DB01013)

IndicationStatusPhase
DBCOND0042053 (Stage IV Colorectal Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02368886Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal CancerTreatment